GlaxoSmithKline PLC(GSK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

GSK GlaxoSmithKline PLC

Market Closed 01-16 16:00:00 EST

48.22

-0.90

-1.83%

盘后48.38

+0.16+0.33%

19:54 EST

High48.93	Low48.09	Vol7.54M
Open48.85	D1 Closing49.12	Amplitude1.71%
Mkt Cap98.27B	Tradable Cap93.88B	Total Shares2.04B
T/O365.36M	T/O Rate0.39%	Tradable Shares1.95B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"GSK","market":"US","secType":"STK","nameCN":"GlaxoSmithKline PLC","latestPrice":48.22,"timestamp":1768597200000,"preClose":49.12,"halted":0,"volume":7543556,"hourTrading":{"tag":"盘后","latestPrice":48.38,"preClose":48.22,"latestTime":"19:54 EST","volume":72306,"amount":3487005.0049,"timestamp":1768611260775,"change":0.16,"changeRate":0.003318,"amplitude":0},"delay":0,"changeRate":-0.018322475570032547,"floatShares":1946891708,"shares":2037944753,"eps":3.572046,"marketStatus":"Market Closed","change":-0.9,"latestTime":"01-16 16:00:00 EST","open":48.85,"high":48.93,"low":48.09,"amount":365361724.75272,"amplitude":0.017101,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":3.572046,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1768899600000},"marketStatusCode":7,"adr":1,"adrRate":2,"listingDate":977893200000,"exchange":"NYSE","adjPreClose":49.12,"dividendRate":0.035143,"preHourTrading":{"tag":"盘前","latestPrice":48.86,"preClose":49.12,"latestTime":"09:29 EST","volume":67483,"amount":3297916.816805,"timestamp":1768573799999,"change":-0.26,"changeRate":-0.005293,"amplitude":0.01364},"postHourTrading":{"tag":"盘后","latestPrice":48.38,"preClose":48.22,"latestTime":"19:54 EST","volume":72306,"amount":3487005.0049,"timestamp":1768611260775,"change":0.16,"changeRate":0.003318,"amplitude":0},"volumeRatio":1.8408641969327026,"impliedVol":0.2934,"impliedVolPercentile":0.6016},"requestUrl":"/m/hq/s/GSK/wiki","defaultTab":"wiki","newsList":[{"id":"2604915166","title":"GSK price target raised to 1,675 GBp from 1,600 GBp at Deutsche Bank","url":"https://stock-news.laohu8.com/highlight/detail?id=2604915166","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604915166?lang=en_us&edition=fundamental","pubTime":"2026-01-17 03:15","pubTimestamp":1768590928,"startTime":"0","endTime":"0","summary":"Deutsche Bank raised the firm’s price target on GSK (GSK) to 1,675 GBp from 1,600 GBp and keeps a Hold rating on the shares. Published first on The...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gsk-price-target-raised-to-1675-gbp-from-1600-gbp-at-deutsche-bank-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gsk-price-target-raised-to-1675-gbp-from-1600-gbp-at-deutsche-bank-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK","DB"],"gpt_icon":0},{"id":"2604091833","title":"All Eyes on Guidance for European Big Pharma Earnings Season -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2604091833","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604091833?lang=en_us&edition=fundamental","pubTime":"2026-01-17 01:03","pubTimestamp":1768582980,"startTime":"0","endTime":"0","summary":"1703 GMT - Big European pharmaceutical stocks have rallied in recent weeks, which makes them vulnerable should companies' 2026 guidance disappoint, Bank of America analysts say in a note. The likely outlooks from AstraZeneca and Novartis look safe relative to consensus expectations, Bank of America says. Meanwhile, there could be some risk that the outlooks issued by GSK, Novo Nordisk and Sanofi fall short of forecasts, according to Bank of America. For Roche, Bank of America expects guidance of sales growth in the mid-single-digit percentage range excluding currency movements and earnings per share growth of high single digits, broadly in line with consensus, but sees room for a more cautious view. The Stoxx Europe 600 Health Care index closes 0.6% higher, and is up 7.25% over the past month. ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2265009873.SGD","LU0070302665.USD","NVS","LU2129689431.USD","LU0320765489.SGD","IE00B2B36J28.USD","LU0321505868.SGD","BK4532","LU0208291251.USD","LU1363072403.SGD","LU0130518102.USD","GSK.UK","IE00BFTCPJ56.SGD","IE0001KFT4U8.USD","LU0971096721.USD","LU0320765646.SGD","GSK","LU0154236417.USD","LU0648001328.SGD","LU1791807156.HKD","LU2129689514.USD","IE00BBT3K403.USD","LU1894683348.USD","LU0098860793.USD","LU1894683264.USD","IE00BJJMRZ35.SGD","LU0648000940.SGD","LU0306807586.USD","LU1201861165.SGD","LU1366192091.USD","BK4534","IE00BZ1G4Q59.USD","IE00B1BXHZ80.USD","LU1093756168.USD","LU2456880835.USD","LU0787776722.HKD","LU2236285917.USD","BK4588","LU2133065610.SGD","LU1093756325.SGD","AZN","BK4007","LU1267930227.SGD","LU1201861249.SGD","LU0130102774.USD","IE0002141913.USD","LU0130517989.USD","LU1880398471.USD","LU0106831901.USD","LU1069347547.HKD","IE0002270589.USD","LU1496350171.SGD","BK4553","LU2129689605.HKD","LU0306806265.USD","LU0417517546.SGD","IE00B19Z3581.USD","LU1829250122.USD","LU0980610538.SGD","LU1668664300.SGD","RHHBY","LU1074936037.SGD","BK4581","LU0310800965.SGD","BK4599","IE00BLSP4239.USD","LU0149725797.USD","IE00B4R5TH58.HKD","BK4578","IE0009355771.USD","03165","IE0034235188.USD","LU0256863811.USD","BK4568","BK4585","LU1035773651.USD","LU0170899867.USD","IE00BKVL7J92.USD","LU0477156797.USD","LU0640476718.USD","LU0256863902.USD","LU0130103400.USD","LU1280957306.USD","BK4559","LU1804176565.USD","LU0203347892.USD","LU0314106906.USD","LU0053666078.USD","LU0052756011.USD","BK4207","LU1162221912.USD","LU0211331839.USD","LU0683600562.USD","IE00BFXG1179.USD","LU0321505439.SGD","LU0477156953.USD","LU0203345920.USD","LU0320765992.SGD","LU0109394709.USD","SNY","IE00B19Z3B42.SGD","IE00BJT1NW94.SGD","IE00B7SZLL34.SGD","IE00BLSP4452.SGD","LU1880398554.USD","BK4504","LU0128525689.USD","LU0868494617.USD","LU1496350502.SGD","LU0889565916.HKD","LU2417539215.USD","LU1506573853.SGD","LU0234572021.USD","LU1718418525.SGD","LU2462157665.USD","LU1883839398.USD"],"gpt_icon":1},{"id":"2603976209","title":"GSK Executives Increase Holdings via Dividend Reinvestment in ADSs","url":"https://stock-news.laohu8.com/highlight/detail?id=2603976209","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603976209?lang=en_us&edition=fundamental","pubTime":"2026-01-16 23:32","pubTimestamp":1768577551,"startTime":"0","endTime":"0","summary":"An announcement from GlaxoSmithKline ( ($GB:GSK) ) is now available. GSK has disclosed several transactions in which senior leaders, including non-...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-executives-increase-holdings-via-dividend-reinvestment-in-adss?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-executives-increase-holdings-via-dividend-reinvestment-in-adss?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4532","BK4585","GSK","GSK.UK","LU1829250122.USD","BK4007"],"gpt_icon":0},{"id":"2603983749","title":"Deutsche Bank  Sticks to Its Hold Rating for GlaxoSmithKline (GSK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2603983749","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603983749?lang=en_us&edition=fundamental","pubTime":"2026-01-16 19:39","pubTimestamp":1768563571,"startTime":"0","endTime":"0","summary":"In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Hold rating on GlaxoSmithKline, with a price target of £16.75. Papad...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/deutsche-bank-sticks-to-its-hold-rating-for-glaxosmithkline-gsk-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/deutsche-bank-sticks-to-its-hold-rating-for-glaxosmithkline-gsk-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK","DB"],"gpt_icon":0},{"id":"2603996728","title":"UBS Keeps Their Hold Rating on GlaxoSmithKline (GSK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2603996728","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603996728?lang=en_us&edition=fundamental","pubTime":"2026-01-16 18:47","pubTimestamp":1768560442,"startTime":"0","endTime":"0","summary":"In a report released today, Matthew Weston from UBS maintained a Hold rating on GlaxoSmithKline, with a price target of p1,940.00. Weston covers th...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/ubs-keeps-their-hold-rating-on-glaxosmithkline-gsk-blurbs-4?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/ubs-keeps-their-hold-rating-on-glaxosmithkline-gsk-blurbs-4?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK"],"gpt_icon":0},{"id":"2603963998","title":"Barclays Remains a Sell on GlaxoSmithKline (GSK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2603963998","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603963998?lang=en_us&edition=fundamental","pubTime":"2026-01-16 15:47","pubTimestamp":1768549669,"startTime":"0","endTime":"0","summary":"Barclays analyst Shirley Chen maintained a Sell rating on GlaxoSmithKline yesterday. The company’s shares closed yesterday at p1,848.00. Chen cover...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/barclays-remains-a-sell-on-glaxosmithkline-gsk-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/barclays-remains-a-sell-on-glaxosmithkline-gsk-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4585","BK4588","LU1829250122.USD","GSK.UK","GSK","BK4532"],"gpt_icon":0},{"id":"2603982698","title":"GSK Slides Thursday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2603982698","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603982698?lang=en_us&edition=fundamental","pubTime":"2026-01-16 01:08","pubTimestamp":1768496880,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.GSK PLC  shares dropped 1.73% to GBP18.48 Thursday, on what proved to be an all-around positive trading session for the stock market, with the FTSE 100 Index  rising 0.54% to 10,238.94.GSK PLC closed 10.19% short of its 52-week high of GBP20.58, which the company reached on December 19th.Trading volume totaled 4.8 million, compared to the 50-day average of 8.2 million.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK"],"gpt_icon":0},{"id":"2603810769","title":"European Equities Traded in the US as American Depositary Receipts Little Changed in Thursday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2603810769","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603810769?lang=en_us&edition=fundamental","pubTime":"2026-01-16 00:12","pubTimestamp":1768493579,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were little changed late Thursday morning, edging 0.02% higher to 1,753.96 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by telecommunications company Nokia  and internet browser company Opera , which rose 4.6% and 3.2%, respectively. They were followed by biopharmaceutical company DBV Technologies  and telecommunications company Ericsson , which were up 1.7% and 1%, respectively.The decliners from continental Europe were led by pharmaceutical company Novo Nordisk  and medical device maker EDAP TMS , which fell 3.8% and 3.7%, respectively. They were followed by oil and gas company Eni  and biopharmaceutical company Grifols , which were down 2.5% and 1.7%, respectively.From the UK and Ireland, the gainers were led by biopharmaceutical company Biodexa Pharmaceuticals  and lender HSBC , which advanced 5.2% and 1.2%, respectively. They were followed by telecommunications operator Vodafone ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4020","E","LU0310800965.SGD","BDRX","LU0154236417.USD","BK4559","BK4169","LU2456880835.USD","LU0109394709.USD","LU1267930227.SGD","IE00BKVL7J92.USD","DGE.UK","EDAP","BK4588","HSBC","AZN","BK4139","NVO","BK4505","GSK","LU2236285917.USD","MREO","BK4023","BK4599","BK4207","BK4521","DBVT","BK4568","GSK.UK","OPRA","BK4201","LU0889565916.HKD","VOD","BK4515","BK4132","LU1093756168.USD","AKTX","LU1829250122.USD","AFG","NVO.AU","GRFS","BK4107","LU0052756011.USD","LU0128525689.USD","ERIC","BK4591","DEO","BK4547","IE00BZ1G4Q59.USD","NOK"],"gpt_icon":1},{"id":"2603981354","title":"GSK Executives Reinvest Dividends in Additional Company Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2603981354","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603981354?lang=en_us&edition=fundamental","pubTime":"2026-01-15 23:32","pubTimestamp":1768491147,"startTime":"0","endTime":"0","summary":"The latest announcement is out from GlaxoSmithKline ( ($GB:GSK) ). GSK plc disclosed that President of Corporate Development David Redfern and Seni...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-executives-reinvest-dividends-in-additional-company-shares?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-executives-reinvest-dividends-in-additional-company-shares?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK.UK","BK4585","BK4588","BK4532","LU1829250122.USD","GSK","BK4007"],"gpt_icon":0},{"id":"2603643942","title":"GSK price target raised to 1,600 GBp from 1,500 GBp at Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2603643942","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603643942?lang=en_us&edition=fundamental","pubTime":"2026-01-15 00:50","pubTimestamp":1768409414,"startTime":"0","endTime":"0","summary":"Morgan Stanley raised the firm’s price target on GSK (GSK) to 1,600 GBp from 1,500 GBp and keeps an Underweight rating on the shares. Published fir...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gsk-price-target-raised-to-1600-gbp-from-1500-gbp-at-morgan-stanley-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gsk-price-target-raised-to-1600-gbp-from-1500-gbp-at-morgan-stanley-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK"],"gpt_icon":0},{"id":"2603648062","title":"J.P. Morgan Remains a Sell on GlaxoSmithKline (GSK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2603648062","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603648062?lang=en_us&edition=fundamental","pubTime":"2026-01-15 00:26","pubTimestamp":1768408014,"startTime":"0","endTime":"0","summary":"In a report released today, Zain Ebrahim from J.P. Morgan maintained a Sell rating on GlaxoSmithKline, with a price target of £17.00. Ebrahim cover...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/j-p-morgan-remains-a-sell-on-glaxosmithkline-gsk-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/j-p-morgan-remains-a-sell-on-glaxosmithkline-gsk-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1791710400.SGD","LU1162221912.USD","LU1989772840.SGD","LU0106831901.USD","LU1668664300.SGD","LU2271345857.HKD","BK4007","BK4534","LU1244550577.SGD","LU2089283258.USD","LU1363072403.SGD","LU0158827948.USD","LU1074936037.SGD","LU1989772923.USD","LU0158827781.USD","GSK.UK","LU2023251221.USD","GSK","LU0098860793.USD","BK4588","LU1732799900.SGD","BK4516","LU2347655156.SGD","BK4532","LU0528227936.USD","LU0971096721.USD","LU1829250122.USD","BK4127","BK4581","LU0225283273.USD","LU0106261372.USD","LU1791710582.SGD","IE00BZ1G4Q59.USD","LU2357305700.SGD","BK4504","LU1548497426.USD","LU0882574139.USD","IE00BKVL7J92.USD","LU1244550494.USD","LU1732800096.USD","LU1720051017.SGD","LU0267386448.USD","LU0912757837.SGD","LU0557290698.USD","LU2028103732.USD","LU0314104364.USD","BK4585","LU1720051108.HKD","LU0795875086.SGD","LU0234570918.USD"],"gpt_icon":0},{"id":"2603635999","title":"GSK Executives Reinvest Dividends into Company Shares via Reward Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2603635999","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603635999?lang=en_us&edition=fundamental","pubTime":"2026-01-13 23:32","pubTimestamp":1768318365,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ( ($GB:GSK) ) just unveiled an announcement. GSK plc has disclosed a series of transactions in which senior executives and a person...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-executives-reinvest-dividends-into-company-shares-via-reward-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-executives-reinvest-dividends-into-company-shares-via-reward-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4532","BK4585","GSK","GSK.UK","LU1829250122.USD","BK4007"],"gpt_icon":0},{"id":"2603681698","title":"FACTBOX-Global drugmakers rush to boost US presence as tariff threat looms","url":"https://stock-news.laohu8.com/highlight/detail?id=2603681698","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603681698?lang=en_us&edition=fundamental","pubTime":"2026-01-13 20:50","pubTimestamp":1768308601,"startTime":"0","endTime":"0","summary":"FACTBOX-Global drugmakers rush to boost US presence as tariff threat loomsChanges dateline, paragraph 1 and updates AbbVie. Global drugmakers are ramping up U.S. manufacturing and stockpiling inventory as the Trump administration considers imposing. a 100% tariff on imported branded and patented medicines.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nL4N3YE0YD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ1G4Q59.USD","IE00BVYPNV92.GBP","LU1883839398.USD","IE00BN29S564.USD","LU0949170772.SGD","LU0225771236.USD","LU0345770993.USD","IE00BN8TJ469.HKD","LU0456855351.SGD","LU1037948541.HKD","LU1548497426.USD","LU2087621335.USD","LU0985320562.USD","LU0499090636.EUR","LU2471134523.USD","LU0997586432.USD","LU1720051017.SGD","LU1032955483.USD","LU2089984988.USD","LU0466842654.USD","LU1712237335.SGD","AMGN","LU1267930490.SGD","LU0432979614.USD","LU1023059063.AUD","SGXZ51526630.SGD","LU0795875086.SGD","LU2242646821.SGD","LU0130517989.USD","LU0689626769.HKD","LU1989772840.SGD","LU0868494617.USD","LU0130102774.USD","IE0004445239.USD","LU1585245621.USD","LU2471134952.CNY","LU0708995401.HKD","LU0889566641.SGD","LU0353189680.USD","IE00BKPKM429.USD","PFE","SG9999015986.USD","LU1551013342.USD","CSL.AU","LU1868836591.USD","LU2491049909.HKD","LU0965509283.SGD","LU2468319806.SGD","LU1051770623.HKD","LU2091194634.USD","LU0477156953.USD","LU2168564222.USD","IE00BFTCPJ56.SGD","LU0920783379.SGD","LU0208291251.USD","LU1104425308.USD","LU1069347547.HKD","LU0265550359.USD","LU0124676726.USD","SG9999014914.USD","LU0526926950.USD","LU0266013472.USD","LU2023250843.SGD","LU1032466523.USD","LU0047473722.SGD","LU0321505439.SGD","IE00B775H168.HKD","LU1244550494.USD","LU1674673691.USD","LU2168563687.JPY","LU2112291526.USD","LU1496350502.SGD","LU0784385840.USD","LU1732800096.USD","LU2430703178.SGD","LU1153584641.USD","LU1880407132.USD","LU1019634622.SGD","LU0980610538.SGD","IE00BDGV0183.EUR","LU0256863811.USD","BK4588","LU1015430645.USD","LU1914381329.SGD","LU0070217475.USD","LU0683600562.USD","LU0912757837.SGD","LU2237443465.HKD","LU1301847155.USD","LU1003077747.HKD","BIIB","NVS","LU1989771016.USD","LU2023251221.USD","LU2236285917.USD","LU1035775433.USD","GSK","SG9999002224.SGD","LU0158827948.USD","LU1093756168.USD","LU2592432038.USD","LU1894683264.USD","LU2552382132.HKD","SGXZ99366536.SGD","BK4559","LU1267930573.SGD","SG9999014898.SGD","LU0077335932.USD","IE0005OL40V9.USD","SG9999014575.USD","LU1003076772.USD","IE00BJJMRZ35.SGD","LU1430594728.SGD","LU0203201768.USD","LU1551013425.SGD","BK4585","LU1718418525.SGD","LU1941712348.USD","JNJ","LU0820561909.HKD","LU2417539215.USD","LU0203345920.USD","LU1732799900.SGD","LU1674673428.USD","LU0965508806.USD","LU2133065610.SGD","LU2552382058.USD","IE00BFSS7M15.SGD","SGXZ57979304.SGD","LU2125154935.USD","BK4592","IE00BKPKM643.USD","LU0029864427.USD","LU0795875169.SGD","LU2114397693.USD","SG9999013999.USD","LU1261432733.SGD","IE0004445015.USD","SG9999001440.SGD","LU1267930227.SGD","IE00B19Z3B42.SGD","SG9999001176.SGD","LU0096364046.USD","LU1280957306.USD","GB00BDT5M118.USD","BK7501","BK7508","BK4568","LU1170363599.USD","BK4532","LU1116320737.USD","LU0345769631.USD","LU1571399168.USD","LU0672654240.SGD","IE00B1BXHZ80.USD","LU0417517546.SGD","LU2357305700.SGD","LU0353189763.USD","LU0471298694.HKD","LU0471298777.SGD","LU1974910355.USD","BK4007","LU1487256676.USD","LU0827474353.SGD","IE00BLSP4452.SGD","LU0289739699.SGD","LU1059921491.USD","LU2129689514.USD","LU1778281490.HKD","BK4139","LU1232071149.USD","LU0323591593.USD","LU0211327993.USD","BK7067","BK5011","LU0109391861.USD","LU1929549753.HKD","LU0128525929.USD","LU1804176565.USD","LU0545039389.USD","LU0661504455.SGD","LU0784384876.USD","LU0211328371.USD","BK4581","LU2089284900.SGD","LU2242652126.USD","LU1868837300.USD","LU1244550577.SGD","SG9999014559.SGD","LU0823434583.USD","LU0784385170.HKD","LU1066051811.HKD","BK4583","LU2129689605.HKD","LU1064927863.SGD","LU1917777945.USD","LU0310799852.SGD","LU1116320901.HKD","LU2461242641.AUD","LU2471134879.HKD","LU0969580561.USD","LU0128525689.USD","LU1868836914.USD","LU2360032135.SGD","LU2168564065.EUR","LU1988902786.USD","LU2505996509.AUD","SG9999014880.SGD","LU1934455863.HKD","LU1934455277.USD","LU2087625088.SGD","LU1037948897.HKD","LU0960981461.USD","LU0052756011.USD","LU0823399737.USD","LU2462157665.USD","BK4504","LU1064131342.USD","IE00BKVL7J92.USD","LU2279689827.SGD","IE00BJJMRX11.SGD","LU0575583348.USD","IE00B42XCP33.USD","LU0943347566.SGD","LU1839511570.USD","IE00BK4W5L77.USD","LU1868837136.USD","IE00BBT3K403.USD","LU2023250504.SGD","LU1201861249.SGD","LU0203202063.USD","LU0109394709.USD","LU1221951046.USD","LU0786609619.USD","IE00BVYPNW00.USD","LU0964806797.USD","LU2106854487.HKD","LU2360106947.USD","IE0009355771.USD","LU0070302665.USD","LU0861579265.USD","LU0238689110.USD","LU0757432116.USD","LU0265550946.USD","LU0738911758.USD","LU0787776722.HKD","LU2361045086.USD","LU0170899867.USD","SG9999015952.SGD","LU0345769128.USD","LU2539964713.USD","IE00BLSP4239.USD","LU0321505868.SGD","BK7511","LLY","LU0058720904.USD","LU1093756325.SGD","LU2237438978.USD","LU0234572021.USD","LU2237443895.HKD","IE00B4R5TH58.HKD","04332","LU0708994859.HKD","LU1935042991.SGD","LU1066051225.USD","LU2293690082.USD","LU1074936037.SGD","IE00BKDWB100.SGD","LU0823416689.USD","BK4550","LU2361044865.SGD","LU1699723380.USD","LU1291159041.SGD","LU2168564495.EUR","LU2264538146.SGD","LU1162221912.USD","LU2211815571.USD","LU0823434740.USD","LU2129689431.USD","ABBV","LU0079474960.USD","LU0882574139.USD","LU1119994496.HKD","SG9999015945.SGD","SG9999002232.USD","LU0225283273.USD","LU0792757196.USD","LU0047473722.EUR","GILD","LU1057294990.SGD","03165","LU0198837287.USD","LU1267930730.SGD","LU2602419157.SGD","LU0889565916.HKD","LU0972486137.USD","LU0320765646.SGD","LU2265009873.SGD","LU1066051498.USD","IE000M9KFDE8.USD","IE00B19Z9P08.USD","LU0345777147.USD","LU2237443382.USD","LU2456880835.USD","LU0310800965.SGD","LU1078025761.USD","IE00B2B36J28.USD","AZN","LU1868836757.USD","SGXZ31699556.SGD","LU0097036916.USD","LU0882574055.USD","SG9999014542.SGD","IE00B894F039.SGD","IE00B1XK9C88.USD","LU2237443549.SGD","IE00B7KXQ091.USD","SG9999014567.USD","LU0557290698.USD","LU0345777659.USD","LU0306806265.USD","IE00BFSS8Q28.SGD","IE00BJT1NW94.SGD","LU0211331839.USD","SG9999017495.SGD","LU2237443978.SGD","LU0963555726.SGD","SG9999011175.SGD","LU0320765992.SGD","SG9999015978.USD","BK4578","IE00B19Z3581.USD","LU2491050071.SGD","LU0820561818.USD","LU2125154778.USD","LU0640478417.SGD","MRK","SNY","LU2361044949.HKD","LU2552382215.SGD","LU1084165304.USD","LU2108987350.USD","IE00BSNM7G36.USD","LU0965509010.AUD","LU0976567544.SGD","IE00BWXC8680.SGD","LU1506573853.SGD","LU0648001328.SGD","BK4566","LU1153585028.USD","LU0965509101.SGD","LU0171293334.USD","LU2063271972.USD","BK4533","LU1127390331.HKD","LU0957799991.USD","LU1623119135.USD","SG9999015358.SGD","LU2746668974.SGD","LU1934455194.USD","LU0354030438.USD","LU1066053197.SGD","LU1366192091.USD","LU0354030511.USD","LU1196500208.SGD","LU2491050154.USD","LU0234570918.USD","IE00BGHQF631.EUR","SG9999018857.SGD","IE00BJLML261.HKD","LU1244550221.USD","LU0211326839.USD","SG9999015341.SGD","IE00B4JS1V06.HKD","LU0211326755.USD","LU1481600234.SGD","LU0784383803.USD","LU1894683348.USD","LU1880407215.USD","IE00B19Z9Z06.USD","LU2430703251.USD","SG9999014906.USD","LU1941712264.USD","LU2505996681.GBP","LU1069344957.HKD","LU0385154629.USD","LU1221951129.SGD","LU0122379950.USD","LU0316494557.USD","LU2293690249.USD","LU0306807586.USD","LU0094547139.USD","SG9999018865.SGD","IE0034235188.USD","LU0114720955.EUR","LU1989772923.USD","IE00B3PB1722.GBP","LU2347655156.SGD","LU0640476718.USD","LU1267930813.SGD","LU0496365809.HKD","LU0320765059.SGD","LU0553294199.USD","LU2471134796.USD","LU2746668461.USD","LU1814569148.SGD","SGXZ81514606.USD","LU0011850046.USD","IE0002141913.USD","IE00B7SZLL34.SGD","LU2750360641.GBP","LU2430703095.HKD","LU0920840948.USD","LU1019632923.USD","LU2324357040.USD","LU0256863902.USD","BK4599","IE00BK4W5M84.HKD","LU1481599808.USD","LU0857590862.USD","LU1323610961.USD","IE00B3T34201.USD","BK4534","LU1035773651.USD","BK4516","IE00BFXG1179.USD","LU0225284248.USD","LU2168564149.EUR","LU0061475181.USD","LU2089283258.USD","LU0098860793.USD","LU0320765489.SGD","LU2750360997.AUD","LU2237443622.USD","IE0034235303.USD","LU0310800379.SGD","LU1496350171.SGD","LU0689472784.USD","LU1061106388.HKD","LU0345770308.USD","LU0106261372.USD","LU0889565080.SGD","LU0006306889.USD","IE0002270589.USD","IE00BJJMRY28.SGD","LU0949170426.SGD","NVO","SG9999003800.SGD","SG9999001176.USD","LU0203347892.USD","LU1720051108.HKD","LU1983299246.USD","LU0985481810.HKD"],"gpt_icon":0},{"id":"2603057908","title":"Investing in healthcare can be a win-win proposition","url":"https://stock-news.laohu8.com/highlight/detail?id=2603057908","media":"The Smart Investor","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603057908?lang=en_us&edition=fundamental","pubTime":"2026-01-13 11:30","pubTimestamp":1768275000,"startTime":"0","endTime":"0","summary":"For one thing, putting money into firms in the sector would ensure that they are around when we need them.","market":"us","thumbnail":"https://thesmartinvestor.com.sg/wp-content/uploads/2021/11/Haw-Par-Group-Products-2021-300x159.png","type":0,"news_type":0,"thumbnails":["https://thesmartinvestor.com.sg/wp-content/uploads/2021/11/Haw-Par-Group-Products-2021-300x159.png"],"rights":{"source":"thesmartinvestor_highlight","url":"https://thesmartinvestor.com.sg/investing-in-healthcare-can-be-a-win-win-proposition/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://thesmartinvestor.com.sg/investing-in-healthcare-can-be-a-win-win-proposition/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"thesmartinvestor_highlight","symbols":["GSK.UK","GSK","BK4588","BK4585","BK4007","BK4532","LU1829250122.USD"],"gpt_icon":0},{"id":"2603425665","title":"GSK Advances New First-in-Human Prostate Cancer Drug Into Early Clinical Testing","url":"https://stock-news.laohu8.com/highlight/detail?id=2603425665","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603425665?lang=en_us&edition=fundamental","pubTime":"2026-01-13 00:31","pubTimestamp":1768235518,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. Study Overview – GlaxoSmithKline (GSK) is launching a first-time-in-hum...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-advances-new-first-in-human-prostate-cancer-drug-into-early-clinical-testing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-advances-new-first-in-human-prostate-cancer-drug-into-early-clinical-testing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK.UK","LU1829250122.USD","BK4585","BK4588","BK4007","BK4532","GSK"],"gpt_icon":0},{"id":"2602517448","title":"Summit Therapeutics Expands Ivonescimab Program With GSK Collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2602517448","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602517448?lang=en_us&edition=fundamental","pubTime":"2026-01-12 20:58","pubTimestamp":1768222701,"startTime":"0","endTime":"0","summary":"An update from Summit Therapeutics ( ($SMMT) ) is now available. On January 12, 2026, Summit Therapeutics presented at the 44th Annual J.P. Morgan ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/summit-therapeutics-expands-ivonescimab-program-with-gsk-collaboration?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/summit-therapeutics-expands-ivonescimab-program-with-gsk-collaboration?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0006306889.USD","LU0882574139.USD","LU1074936037.SGD","LU1363072403.SGD","LU1732799900.SGD","LU1732800096.USD","LU2347655156.SGD","BK4588","BK4539","LU1244550577.SGD","LU0158827781.USD","LU0795875169.SGD","LU1989772923.USD","GSK.UK","LU0314104364.USD","BK4139","BK4581","BK4516","LU0158827948.USD","LU0557290698.USD","GSK","LU2089283258.USD","LU2133065610.SGD","LU0234570918.USD","LU0795875086.SGD","LU1720051017.SGD","BK4532","LU0267386448.USD","LU0528227936.USD","LU1244550221.USD","LU1829250122.USD","BK4007","SMMF","BK4211","LU2357305700.SGD","LU0971096721.USD","LU1989772840.SGD","LU2089284900.SGD","IE00BZ1G4Q59.USD","LENZ","LU0912757837.SGD","LU1548497426.USD","LU2028103732.USD","LU2023251221.USD","LU2111349929.HKD","LU2271345857.HKD","BK4585","LU1791710582.SGD","LU1791710400.SGD","LU1668664300.SGD"],"gpt_icon":0},{"id":"2602230517","title":"AnaptysBio Pushes Back Against Lawsuit Over Cancer Drug Jemperli Royalties","url":"https://stock-news.laohu8.com/highlight/detail?id=2602230517","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602230517?lang=en_us&edition=fundamental","pubTime":"2026-01-10 02:56","pubTimestamp":1767984960,"startTime":"0","endTime":"0","summary":"AnaptysBio asks a Delaware court to dismiss Tesaro's breach claim, citing anti-SLAPP law in a dispute over Jemperli royalties and licensing rights.","market":"hk","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/01/09/Genetic-Research-And-Biotech-Science-Con.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/01/09/Genetic-Research-And-Biotech-Science-Con.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/legal/26/01/49822049/anaptysbio-pushes-back-against-lawsuit-over-cancer-drug-jemperli-royalties","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/legal/26/01/49822049/anaptysbio-pushes-back-against-lawsuit-over-cancer-drug-jemperli-royalties","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4532","GSK.UK","BK4588","BK4585","ANAB","GSK","BK4139","LU1829250122.USD","BK4007"],"gpt_icon":0},{"id":"2602902323","title":"GlaxoSmithKline (GSK) Receives a Buy from Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2602902323","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602902323?lang=en_us&edition=fundamental","pubTime":"2026-01-09 04:25","pubTimestamp":1767903940,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Michael Leuchten from Jefferies reiterated a Buy rating on GlaxoSmithKline, with a price target of p2,100.00. The c...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-receives-a-buy-from-jefferies-blurbs-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-receives-a-buy-from-jefferies-blurbs-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","GSK","BK4585","BK4588","GSK.UK","BK4532","LU1829250122.USD"],"gpt_icon":0},{"id":"2602915053","title":"LIXTE Biotechnology Holdings (NASDAQ: LIXT) Expands Ovarian Cancer Trial With MD Anderson and GSK","url":"https://stock-news.laohu8.com/highlight/detail?id=2602915053","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602915053?lang=en_us&edition=fundamental","pubTime":"2026-01-09 01:00","pubTimestamp":1767891614,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, January 8th, 2026, FinanceWire LIXTE Biotechnology Holdings (NASDAQ: LIXT) announced an expansion of its collabo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/lixte-biotechnology-holdings-nasdaq-lixt-expands-ovarian-cancer-trial-with-md-anderson-and-gsk?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/lixte-biotechnology-holdings-nasdaq-lixt-expands-ovarian-cancer-trial-with-md-anderson-and-gsk?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NQmain","SQQQ","BK4007","QLD","GSK.UK","GSK","BK4588","QID","LIXT","TQQQ","MNQmain","BK4532","LU1829250122.USD",".IXIC","PSQ","USJW.SI","BK4139","MD","NVIW.SI","BK4196","BK4585","TSYW.SI","USAW.SI"],"gpt_icon":0},{"id":"1147497837","title":"GSK's Breakthrough Hepatitis B Therapy Meets Primary Endpoints in Phase 3 Trials, Regulatory Filing Imminent","url":"https://stock-news.laohu8.com/highlight/detail?id=1147497837","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147497837?lang=en_us&edition=fundamental","pubTime":"2026-01-08 08:50","pubTimestamp":1767833423,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline PLC (GSK.US) announced today that bepirovirsen, an investigational antisense oligonucleotide (ASO) therapy developed in collaboration with Ionis Pharmaceuticals, has achieved positive...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LU1829250122.USD","BK4532","GSK","BK4588","GSK.UK","BK4585"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.gsk.com","stockEarnings":[{"period":"1week","weight":-0.0431},{"period":"1month","weight":-0.0101},{"period":"3month","weight":0.0982},{"period":"6month","weight":0.328},{"period":"1year","weight":0.442},{"period":"ytd","weight":-0.0167}],"compareEarnings":[{"period":"1week","weight":-0.0035},{"period":"1month","weight":0.0302},{"period":"3month","weight":0.041},{"period":"6month","weight":0.1021},{"period":"1year","weight":0.1691},{"period":"ytd","weight":0.0143}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"GSK plc, together with its subsidiaries, engages in the research, development and manufacture of vaccines and specialty medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as infectious disease, HIV, immunology and respiratory, and oncology. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is based in Brentford, the United Kingdom.","yearOnYearQuotes":[{"month":1,"riseRate":0.565217,"avgChangeRate":0.012311},{"month":2,"riseRate":0.466667,"avgChangeRate":-0.001972},{"month":3,"riseRate":0.622222,"avgChangeRate":0.021018},{"month":4,"riseRate":0.673913,"avgChangeRate":0.032633},{"month":5,"riseRate":0.413043,"avgChangeRate":-0.008096},{"month":6,"riseRate":0.586957,"avgChangeRate":0.009648},{"month":7,"riseRate":0.543478,"avgChangeRate":0.003945},{"month":8,"riseRate":0.586957,"avgChangeRate":0.005806},{"month":9,"riseRate":0.521739,"avgChangeRate":0.005973},{"month":10,"riseRate":0.521739,"avgChangeRate":0.013062},{"month":11,"riseRate":0.478261,"avgChangeRate":0.009917},{"month":12,"riseRate":0.608696,"avgChangeRate":0.014188}],"exchange":"NYSE","name":"GlaxoSmithKline PLC","nameEN":"GlaxoSmithKline PLC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GlaxoSmithKline PLC(GSK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest GlaxoSmithKline PLC(GSK) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"GlaxoSmithKline PLC,GSK,GlaxoSmithKline PLC股票,GlaxoSmithKline PLC股票老虎,GlaxoSmithKline PLC股票老虎国际,GlaxoSmithKline PLC行情,GlaxoSmithKline PLC股票行情,GlaxoSmithKline PLC股价,GlaxoSmithKline PLC股市,GlaxoSmithKline PLC股票价格,GlaxoSmithKline PLC股票交易,GlaxoSmithKline PLC股票购买,GlaxoSmithKline PLC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GlaxoSmithKline PLC(GSK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest GlaxoSmithKline PLC(GSK) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}